title: [15+/-deoxyspergualin, hope for patients with multiple sclerosis?].
authors.affiliation: Neurologische Universitätsklinik, Kantonsspital Basel.
authors.forename: L
authors.initials: L
authors.lastname: Kappos
authors.forename: K
authors.initials: K
authors.lastname: Theobald
authors.forename: H P
authors.initials: HP
authors.lastname: Hartung
mesh_terms: D000818:Animals; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D006146:Guanidines / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
chemical_list: D006146:Guanidines; D007166:Immunosuppressive Agents; C037258:gusperimus
vernacular_title: 15 +/- Deoxyspergualin, eine Hoffnung für MS-Betroffene?